Mass testing for discovery and control of COVID-19 outbreaks in adult social care: an observational study and cost-effectiveness analysis of 14 805 care homes in England.
Chen S. et al, (2025), BMJ Public Health, 3
Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda.
Nakabembe E. et al, (2025), Lancet Glob Health, 13, e81 - e97
Understanding COVID-19 testing behaviour in England through a sociodemographic lens : a population based study
Bajaj S. et al, (2024), The Lancet Digital Health
Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT
Iro MA. et al, (2024), Efficacy and Mechanism Evaluation, 1 - 53
Decision to self-isolate during the COVID-19 pandemic in the UK: a rapid scoping review.
Keene CM. et al, (2024), BMJ Open, 14
Seroepidemiology of SARS-CoV-2 in a cohort of pregnant women and their infants in Uganda and Malawi.
Hookham L. et al, (2024), PLoS One, 19
Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial.
Hill M. et al, (2023), BMJ Open, 13
Understanding COVID-19 testing behaviour in England through a sociodemographic lens
Bajaj S. et al, (2023)
SARS-CoV-2 seroprevalence in pregnant women in Kilifi, Kenya from March 2020 to March 2022.
Koech A. et al, (2023), Front Public Health, 11
Group B Streptococcus (GBS) colonization is dynamic over time, whilst GBS capsular polysaccharides-specific antibody remains stable.
Haeusler IL. et al, (2022), Clin Exp Immunol, 209, 188 - 200
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
Costa Clemens SA. et al, (2022), Lancet, 399, 521 - 529